MENU
BIOA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioAge Labs (BIOA) Ownership - Who owns BioAge Labs?
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging... Show more
Profile
Industry
Chemicals Specialty
Address
Suite 4310
Phone
+1.514.844.8000
Employees
85
Web
http://www.bio-amber.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.33M
P/E Ratio
N/A
Total Cash
4.63M
Projected Growth
N/A
Total Debt
37.62M
Revenue
5.4M
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
53.55
Revenue/Share
0.08 USD as % of share price
Fundamentals
BIOA
Capitalization
1.33M
P/E Ratio
N/A
Risk (Beta)
0.57
Dividend Yield
0.00
Total Cash
4.63M
Total Cash/Share
0.07
Total Debt
37.6M
Total Debt/Equity
53.55
Projected Growth (PEG Ratio)
0.00
Revenue/Share (as % of the share price)
0.08%
Revenue
5.4M
ROE
N/A
Book Value
21.9M
P/B Ratio
0.06
Cash Flow
N/A
Earnings
-1.23
Average Daily Volume YTD
1.37M
Common Shares Outstanding - Security Level
68.1M
Current Ratio
1.35
Current Revenue Per Employee
0.18
Dividends Per Share - Security
0.00
EBITDA
-4.79M
Float
16.6M
Float - Current
122M
Gross Income Margin
-44.78
Revenue To Assets
0.21
Shares Held By Institutions
627K
Shares Outstanding - Current
129M
Total Liabilities
47.7M
Total Volume MTD
8.05M
Value
N/A
Gain YTD
-33.161
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts